Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy

Por Chun, Patrick, Wainberg, Zev A.
Publicado em 2009

Targeted Therapies for Metastatic Esophagogastric Cancer

Por Reddy, Deepa, Wainberg, Zev A.
Publicado em 2011

Safety Considerations of Cancer Nanomedicine – A key step towards translation

Por Liu, Xiangsheng, Tang, Ivanna, Wainberg, Zev A., Meng, Huan
Publicado no Small (2020)

Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis

Por Klempner, Samuel J., Maron, Steven B., Chase, Leah, Lomnicki, Samantha, Wainberg, Zev A., Catenacci, Daniel V.T.
Publicado no Oncologist (2018)

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma...

Por Benson, Al B., Wainberg, Zev A., Hecht, J. Randolph, Vyushkov, Dmitry, Dong, Hua, Bendell, Johanna, Kudrik, Fred
Publicado no Oncologist (2017)

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

Por Goldberg, Richard M, Montagut, Clara, Wainberg, Zev A, Ronga, Philippe, Audhuy, François, Taieb, Julien, Stintzing, Sebastian, Siena, Salvatore, Santini, Daniele
Publicado no ESMO Open (2018)

Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors

Por Hoffman, Justin, Chakrabarti, Jayeta, Plotka, Anna, Milillo Naraine, Adriana, Kanamori, David, Moroose, Rebecca, Nguyen, Linh, Wang, Diane, Wainberg, Zev A.
Publicado no Anticancer Drugs (2019)

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

Por Britten, Carolyn D, Gomes, Antoinette S, Wainberg, Zev A, Elashoff, David, Amado, Rafael, Xin, Yan, Busuttil, Ronald W, Slamon, Dennis J, Finn, Richard S
Publicado em 2012

CA19-9 Normalization During Pre-Operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer

Por Williams, Jennifer L., Kadera, Brian E., Nguyen, Andrew H., Muthusamy, V. Raman, Wainberg, Zev A., Hines, O. Joe, Reber, Howard A., Donahue, Timothy R.
Publicado no J Gastrointest Surg (2016)

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

Por von Mehren, Margaret, Britten, Carolyn D., Pieslor, Peter, Saville, Wayne, Vassos, Artemios, Harris, Sarah, Galluppi, Gerald R., Darif, Mohamed, Wainberg, Zev A., Cohen, Roger B., Leong, Stephen
Publicado em 2014

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabi...

Por Wainberg, Zev A., Feeney, Kynan, Lee, Myung Ah, Muñoz, Andrés, Gracián, Antonio Cubillo, Lonardi, Sara, Ryoo, Baek-Yeol, Hung, Annie, Lin, Yong, Bendell, Johanna, Hecht, J. Randolph
Publicado no BMC Cancer (2020)

Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer

Por Court, Colin M., Ankeny, Jacob S., Sho, Shonan, Winograd, Paul, Hou, Shuang, Song, Min, Wainberg, Zev A., Girgis, Mark D., Graeber, Thomas G., Agopian, Vatche G., Tseng, Hsian-Rong, Tomlinson, James S.
Publicado no Ann Surg Oncol (2018)

Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer

Por Court, Colin M., Ankeny, Jacob S., Sho, Shonan, Hou, Shuang, Li, Qingyu, Hsieh, Carolyn, Song, Min, Liao, Xinfang, Rochefort, Matthew M., Wainberg, Zev A., Graeber, Thomas G., Tseng, Hsian-Rong, Tomlinson, James S.
Publicado no J Mol Diagn (2016)

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

Por Catenacci, Daniel V.T., Rasco, Drew, Lee, Jeeyun, Rha, Sun Young, Lee, Keun-Wook, Bang, Yung Jue, Bendell, Johanna, Enzinger, Peter, Marina, Neyssa, Xiang, Hong, Deng, Wei, Powers, Janine, Wainberg, Zev A.
Publicado no J Clin Oncol (2020)

Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1

Por Liu, Xiangsheng, Jiang, Jinhong, Liao, Yu‐Pei, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Lin, Matthew, Wang, Xiang, Ji, Ying, Mei, Kuo‐Ching, Liu, Qi, Chang, Chong Hyun, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Publicado no Adv Sci (Weinh) (2021)

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

Por Tanaka, Hiroshi, Kono, Evelyn, Tran, Chau P, Miyazaki, Hideyo, Yamashiro, Joyce, Shimomura, Tatsuya, Fazli, Ladan, Wada, Robert, Huang, Jiaoti, Vessella, Robert L, An, Jaibin, Horvath, Steven, Gleave, Martin, Rettig, Matthew B, Wainberg, Zev A, Reiter, Robert E
Publicado em 2010

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer

Por Subbiah, Vivek, Kreitman, Robert J., Wainberg, Zev A., Cho, Jae Yong, Schellens, Jan H.M., Soria, Jean Charles, Wen, Patrick Y., Zielinski, Christoph, Cabanillas, Maria E., Urbanowitz, Gladys, Mookerjee, Bijoyesh, Wang, Dazhe, Rangwala, Fatima, Keam, Bhumsuk
Publicado no J Clin Oncol (2018)

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer

Por Wainberg, Zev A., Alsina, Maria, Soares, Heloisa P., Braña, Irene, Britten, Carolyn D., Del Conte, Gianluca, Ezeh, Patrick, Houk, Brett, Kern, Kenneth A., Leong, Stephen, Pathan, Nuzhat, Pierce, Kristen J., Siu, Lillian L., Vermette, Jennifer, Tabernero, Josep
Publicado no Target Oncol (2017)

Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer

Por Liu, Xiangsheng, Jiang, Jinhong, Chan, Ryan, Ji, Ying, Lu, Jianqin, Liao, Yu-Pei, Okene, Michael, Lin, Joshua, Lin, Paulina, Chang, Chong Hyun, Wang, Xiang, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Publicado no ACS Nano (2018)

Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study

Por Bendell, Johanna, Sharma, Sunil, Patel, Manish R., Windsor, Kevin S., Wainberg, Zev A., Gordon, Michael, Chaves, Jorge, Berlin, Jordan, Brachmann, Carrie Baker, Zavodovskaya, Marianna, Liu, JieJane, Thai, Dung, Bhargava, Pankaj, Shah, Manish A., Khan, Saad A., Starodub, Alexander
Publicado no Oncologist (2020)